Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Matthieu Bosset
Observed name:
M. Bosset
Institution:
Hospices Civils de Lyon
Observed institution:
Hospices Civils de Lyon
OpenAlex ID:
A5000847176
Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trial
2025
·
Jean Bourhis
, Anne Aupérin
, et al.
·
The Lancet
·
95
Long-Term Outcome of Lobectomy for Thyroid Cancer
2020
·
Matthieu Bosset
, Maxime Bonjour
, et al.
·
European Thyroid Journal
·
32
PDF
Sodium butyrate with UCN-01 has marked antitumour activity against cervical cancer cells.
2010
·
Anne-Zélie Decrion-Barthod
, Matthieu Bosset
, et al.
·
PubMed
·
19
1331P TPFm (GORTEC 2019-01): Randomized, non-comparative phase II evaluating induction chemotherapy with cisplatin (P), 5-fluorouracil (F) and docetaxel (T) at standard (TPF) or adapted doses (mTPF) in patients (pts) with locally advanced squamous cell cancer of the head and neck (LA-SCCHN)
2025
·
J. Fayette
, L. Loriguet
, et al.
·
Annals of Oncology
Devenir après lobectomie pour cancer thyroïdien différencié dans une cohorte de 291 patients
2015
·
M. Bosset
, C. Bournaud-Salinas
, et al.
·
Annales d Endocrinologie
Show more works
View as search
Works count:
5
Citation count:
143
H-index:
3
I10-index:
3
Year
Topic
Type